%0 Journal Article
%T ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance
%A Changqie Pan
%A Jianping Bin
%A Junhao Zhang
%A Kai Qian
%A Li Lin
%A Min Shi
%A Ruoyang Shao
%A Wangjun Liao
%A Wanying Lin
%A Xiaoyin Li
%A Yantan Liu
%A Yuhao Luo
%A Yulin Liao
%J Archive of "Cell Death & Disease".
%D 2019
%R 10.1038/s41419-019-1362-2
%X a Relative expressions of ATXN2L mRNA in 27 pairs of GC tissues and adjacent noncancerous tissues from The Cancer Genome Atlas dataset. b ATXN2L protein expressions by Western blot analysis in fresh GC tissues and paired noncancerous tissues. c Representative immunohistochemical staining of ATXN2L in different TNM stage GC tissues. d The frequency of high and low ATXN2L expressions in GC patients when categorized by TNM stages, recurrent patients of stage I¨CIII and decedent of stage IV. The number of patients in each stage was noted in the bars. Higher ATXN2L level indicates e shorter overall survival in stage IV patients, as well as f shorter recurrence-free survival in stage I¨CIII patients. g Kaplan-Meier analysis of stage I¨CIII patient recurrence-free survival time by different TNM stages. Higher ATXN2L level indicates shorter recurrence-free survival in h stage I¨CII patients and i stage III patient
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382779/